Neurology

Artificial sweeteners should not be considered a healthy and safe alternative to sugar, caution French investigators.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Ernest R. Gelb, DO, 126th president of the American Osteopathic Association.

The dextromethorphan HBr-bupropion HCI combination uses the first new oral MOA in 6 decades and is labeled to improve depressive symptoms starting at 1 week.

The recommendations guide initiation of statin therapy in persons aged ≥40 years without a history of CVD and no current signs/symptoms of CVD.

Screening for atrial fibrillation with 6 wrist-worn wearable devices proved more cost effective than no screening and had greater relative benefit than using traditional modalities.

Antiplatelet medication was associated with a 63% increase in heat-related MI risk and ß-blockers with a 65% increase. People taking both drugs had a 75% higher risk.

The USPSTF guidance supports shared decision making with patients without CVD risk factors who may benefit from behavioral counseling on diet and physical activity.

A new study compared the differential effects of agents used to treat hypertension on the risk for dementia in patients with hypertension and mild cognitive impairment.

These 11 studies of cardiovascular and metabolic disease prevention, assessment, and treatment were top trending topics on Patient Care in the first half of 2022.

Three-quarters of stroke patients in a Swiss registry had at least 1 undiagnosed risk factor at the time of the event, most commonly hyperlipidemia or hypertension.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Henry Mahncke, PhD, on the impact of cannabis on cognitive health.

If the atogepant label is expanded, the drug will be the only gepant approved for the broad indication of prevention of both episodic and chronic migraine.

Statin-treated patients at high atherosclerotic risk experienced significantly slower progression of arterial stiffness vs those not taking statins in a cohort of more than 5000 patients.

ADA 2022: In a real-world study of nearly half a million adults with T2D followed for 5 years, the SGLT-2 inhibitor surpassed both other classes used in routine clinical care.

One-half of more than 600 000 patients with ASCVD were not prescribed statins at all and only 22.5% were taking a high intensity statin, according to a recent study.

Episodic or chronic? Distinguishing between the 2 types of migraine is essential to ensure optimal treatment. Meet Abigail and Martin. Who has which headache?  

Among more than 3000 participants with prediabetes, neither metformin or lifestyle change reduced risk for CV events over 21 years according to Diabetes Prevention Program Outcomes Study investigators.

Henry Mahncke, PhD, explains why lifestyle interventions, such as diet and exercise, could be prescribed down the line to improve brain health.

Black patients hospitalized with atrial fibrillation were 25% less likely to receive oral anticoagulants upon discharge according to a large national registry study.

Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.

USPSTF states low-dose aspirin should be considered for CVD prevention on a case-by-case basis in adults aged 40-59 yrs with a 10% or greater 10-year CVD risk.

Yale headache specialist Christopher Gottschalk, MD, talks about the opportunities to make a marked difference in the quality of patients' lives.

Researchers in Spain found that suicide was higher among physicians than the general population and affected female physicians significantly more.

Persons with ASCVD who quit smoking could gain 5 more years of life--similar to the outcome of intensive medical treatment while continuing to smoke.

US patients diagnosed with migraine: 40 million. US headache specialists: 600. Primary care is the answer, according to Christopher Gottschalk, MD.